AAV-ChR2 was used for optogenetic manipulation. AAV-hM3Dq was used for chemogenetics manipulation. (From
BrainVTA)
The viruses used in this article from BrainVTA are in the table below
Optogenetic |
PT-0001 AAV-DIO-ChR2-EYFP
PT-0002 AAV-retro-DIO-ChR2-mCherry |
Chemogenetics |
PT-0042 AAV-DIO-hM3Dq-mCherry |
CRE Recombinase |
PT-2947 AAV-TH-Cre |
Feng He, Pei Zhang, Qian Zhang, Guangjian Qi, Hongwei Cai, Tongxia Li, Ming Li, Jiazhen Lu, Jiaen Lin, Jie Ming, Bo Tian
Pub Date: 2021-08-12,
DOI: 10.1007/s12035-021-02522-7,
Email: sales@brainvta.com
Numerous human clinical studies have suggested that decreased locomotor activity is a common symptom of major depressive disorder (MDD), as well as other psychiatric diseases. In MDD, the midbrain ventral tegmental area (VTA) dopamine (DA) neurons are closely related to regulate the information processing of reward, motivation, cognition, and aversion. However, the neural circuit mechanism that underlie the relationship between VTA-DA neurons and MDD-related motor impairments, especially hypolocomotion, is still largely unknown. Herein, we investigate how the VTA-DA neurons contribute to the hypolocomotion performance in chronic social defeat stress (CSDS), a mouse model of depression-relevant neurobehavioral states. The results show that CSDS could affect the spontaneous locomotor activity of mice, but not the grip strength and forced locomotor ability. Chemogenetic activation of VTA-DA neurons alleviated CSDS-induced hypolocomotion. Subsequently, quantitative whole-brain mapping revealed decreased projections from VTA-DA neurons to substantia nigra pars reticulata (SNr) after CSDS treatment. Optogenetic activation of dopaminergic projection from VTA to SNr with the stimulation of phasic firing, but not tonic firing, could significantly increase the locomotor activity of mice. Moreover, chemogenetic activation of VTA-SNr dopaminergic circuit in CSDS mice could also rescued the decline of locomotor activity. Taken together, our data suggest that the VTA-SNr dopaminergic projection mediates CSDS-induced hypolocomotion, which provides a theoretical basis and potential therapeutic target for MDD.
Figure 1. Whole-brain mapping of the outputs of ventral tegmental area (VTA) dopamine neurons in chronic social defeat stress mice.
In this study, the authors have investigated the behavioral adaptations of locomotor activity following CSDS and the role of VTA-DA neurons. Collectively, dopaminergic projections from VTA to SNr appear to mediate CSDS-induced hypolocomotion, and this circuit may be involved in MDD.
BrainVTA offers viral vector construction & virus packaging services for AAV, LV, RABV, PRV, HSV and VSV that help researchers explore questions about genes, neurons, circuitry structure, function of brain network, mechanism and treatment of diseases.
If you have any needs, just email us at
sales@brainvta.com.